Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis
Wilian Correa-Macedo1,2,3, Vinicius M Fava2,3, Marianna Orlova2,3
1Department of Biochemistry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Abstract:
Persons living with HIV (PLWH) are at increased risk of tuberculosis (TB). HIV-associated TB is often the result of recent infection with Mycobacterium tuberculosis (M. tuberculosis) followed by rapid progression to disease. Alveolar macrophages (AMs) are the first cells of the innate immune system that engage M. tuberculosis, but how HIV and antiretroviral therapy (ART) affect the anti-mycobacterial response of AMs is not known. To investigate the impact of HIV and ART on the transcriptomic and epigenetic response of AMs to M. tuberculosis, we obtained AMs by bronchoalveolar lavage from 20 PLWH receiving ART, 16 control subjects who were HIV-free (HC), and 14 subjects who received ART as preexposure prophylaxis (PrEP) to prevent HIV infection. Following in vitro challenge with M. tuberculosis, AMs from each group displayed overlapping but distinct profiles of significantly up- and downregulated genes in response to M. tuberculosis. Comparatively, AMs isolated from both PLWH and PrEP subjects presented a substantially weaker transcriptional response. In addition, AMs from HC subjects challenged with M. tuberculosis responded with pronounced chromatin accessibility changes while AMs obtained from PLWH and PrEP subjects displayed no significant changes in their chromatin state. Collectively, these results revealed a stronger adverse effect of ART than HIV on the epigenetic landscape and transcriptional responsiveness of AMs.
Insights
Antiretroviral therapy (ART) significantly impacts immune cells more than HIV itself, weakening the response of alveolar macrophages to tuberculosis. This finding is crucial for understanding tuberculosis risk in people living with HIV.
Area of Science:
- Immunology
- Infectious Diseases
- Genomics
Background:
- Persons living with HIV (PLWH) face a heightened risk of tuberculosis (TB), often due to rapid progression after Mycobacterium tuberculosis infection.
- Alveolar macrophages (AMs) are critical innate immune cells interacting with M. tuberculosis, but the effects of HIV and antiretroviral therapy (ART) on their anti-mycobacterial functions are unclear.
Purpose of the Study:
- To investigate the impact of HIV and ART on the transcriptomic and epigenetic responses of AMs to M. tuberculosis.
- To compare the immune responses of AMs from PLWH on ART, HIV-negative controls (HC), and individuals on ART for pre-exposure prophylaxis (PrEP).
Main Methods:
- AMs were isolated via bronchoalveolar lavage from three groups: PLWH on ART, HC, and PrEP subjects.
- Isolated AMs were challenged in vitro with M. tuberculosis.
- Transcriptomic and epigenetic (chromatin accessibility) analyses were performed on the AMs.
Main Results:
- AMs from all groups showed distinct gene expression profiles upon M. tuberculosis challenge.
- AMs from both PLWH and PrEP groups exhibited a significantly weaker transcriptional response compared to HC.
- While HC AMs showed pronounced chromatin accessibility changes, AMs from PLWH and PrEP groups displayed no significant epigenetic alterations.
Conclusions:
- ART appears to have a more substantial adverse effect on the epigenetic landscape and transcriptional responsiveness of AMs than HIV infection itself.
- These findings highlight the complex interplay between HIV, ART, and the innate immune system's ability to combat M. tuberculosis.
- Understanding these effects is vital for developing strategies to mitigate TB risk in vulnerable populations.
More Related Videos
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
